Evidence map›Paper›PMID 39456453›Full record

ArticleAntioxidants (Basel, Switzerland)2024

NADPH Oxidase 5 (NOX5) Upregulates MMP-10 Production and Cell Migration in Human Endothelial Cells.

Javier Marqués, Elena Ainzúa, Josune Orbe, María Martínez-Azcona, José Martínez-González, Guillermo Zalba

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Javier MarquésNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0002-3075-8520
Elena AinzúaNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
Josune OrbeNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0001-6300-7670
María Martínez-AzconaNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
José Martínez-GonzálezInstituto de Investigaciones Biomédicas de Barcelona-Consejo Superior de Investigaciones Científicas (IIBB-CSIC), 08036 Barcelona, Spain.ORCID 0000-0002-3894-7166
Guillermo ZalbaNavarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.ORCID 0000-0003-4616-1523

Funding

departments of Health (40/2021) University, Innovation and Digital Transformation (Proyectos I+D colaborativos 2020-PC159/160/161, NOXICTUS) from the Government of Navarra 40/2021Spanish Ministry of Science and Innovation (Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias PI22/01450
6 · The paper itself

Abstract

NADPH oxidases (NOXs) have been described as critical players in vascular remodeling, a mechanism modulated by matrix metalloproteinases. In this study, we describe for the first time the upregulation of MMP-10 through the activation of NOX5 in endothelial cells. In a chronic NOX5 overexpression model in human endothelial cells, MMP-10 production was measured at different levels: extracellular secretion, gene expression (mRNA and protein levels), and promoter activity. Effects on cell migration were quantified using wound healing assays. NOX5 overexpression increased MMP-10 production, favoring cell migration. In fact, NOX5 and MMP-10 silencing prevented this promigratory effect. We showed that NOX5-mediated MMP-10 upregulation involves the redox-sensitive JNK/AP-1 signaling pathway. All these NOX5-dependent effects were enhanced by angiotensin II (Ang II). Interestingly, MMP-10 protein levels were found to be increased in the hearts of NOX5-expressing mice. In conclusion, we described that NOX5-generated ROS may modulate the MMP-10 expression in endothelial cells, which leads to endothelial cell migration and may play a key role in vascular remodeling.

Indexed as

AP-1cell migrationendothelial cellsMMP-10NADPH oxidase 5oxidative stress

Identifiers

PMID39456453
PMCPMC11504164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.